Filing Details
- Accession Number:
- 0001225208-13-004368
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-15 16:43:53
- Reporting Period:
- 2013-02-14
- Filing Date:
- 2013-02-15
- Accepted Time:
- 2013-02-15 16:43:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 912513 | Cytec Industries Inc | CYT | Miscellaneous Chemical Products (2890) | 223268660 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1431512 | Regina M Charles | Five Garret Mountain Plaza Woodland Park NJ 07424 | Vp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-14 | 9,000 | $22.45 | 17,321 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-14 | 6,965 | $51.49 | 24,286 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-14 | 4,667 | $37.59 | 28,953 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-02-14 | 3,250 | $50.33 | 32,203 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-14 | 2,590 | $74.87 | 29,613 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-02-14 | 4,667 | $74.87 | 24,946 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-02-14 | 5,533 | $74.88 | 19,413 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-02-14 | 9,000 | $74.89 | 10,413 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option Right to buy | Disposition | 2013-02-14 | 6,965 | $0.00 | 6,965 | $51.49 |
| Common Stock | Option Right to buy | Disposition | 2013-02-14 | 4,667 | $0.00 | 4,667 | $37.59 |
| Common Stock | Option Right to buy | Disposition | 2013-02-14 | 9,000 | $0.00 | 9,000 | $22.45 |
| Common Stock | Option Right to buy | Disposition | 2013-02-14 | 3,250 | $0.00 | 3,250 | $50.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,483 | 2021-01-25 | No | 4 | M | Direct | |
| 0 | 2020-01-27 | No | 4 | M | Direct | |
| 0 | 2019-01-28 | No | 4 | M | Direct | |
| 6,501 | 2022-01-29 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,986 | Indirect | Savings Plan |
Footnotes
- The sales price ranged from $74.8 to $74.92 with a weighted average of $74.8712. The undersigned reporting person hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The sales price ranged from $74.8 to $74.94 with a weighted average of $74.8743. The undersigned reporting person hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The sales price ranged from $74.79 to $74.94 with a weighted average of $74.8782. The undersigned reporting person hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The sales price ranged from $74.8 to $74.97 with a weighted average of $74.8933. The undersigned reporting person hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Excludes shares held in Employees' Savings Plan or Supplemental Plan which are eligible for deferred reporting on Form 5, as per note to instruction 4(a)(i).
- One-third of the options became exercisable on each of 01/26/2012 and 01/26/2013 and the remaining one-third will become exercisable on 01/26/2014.
- One-third of the options became exercisable on each of 01/28/2011, 01/28/2012 and 01/28/2013.
- One-third of the options became exercisable on each of 01/29/2010, 01/29/2011 and 01/29/2012.
- One-third of the options became exercisable on 01/30/2013 and the remaining two-thirds will become exercisable on each of 01/30/2014 and 01/30/2015.
Billionaire Hedge Funds
